㕦㕦
ᔊқᖍ
㕐
બ˴ܵ
㕻㖑㖞㕐㕳㖘㖙㕐㕸㖟㖞
㕐
ၝΥజኬ
㕐
ᛘ٫
ڦ
ᇌ
ᇜ፨͛jઆλfҢ˚
ۃ
ʔٝ݊щҩə໔༧dБ༩ʕd߉ช̛ਉʃၺ
೨פ
dနַЇ໔
ԂdʔঐБdБ
೨ۆ
d๊ࢹ
ܝ
λdᐼၑঐ
ۈ
੶БΫ༁f;ࢹ
೨ܝ
နಯdШᏀ໔
Ԃஈʥ೨fᔼ͛Ⴍj̙ঐ݊ҩෆdШΪЫϋᙧʔʃə
(75
๋
)
ࠅ
Ͻᅇ݊щઃɪɨ
ٮ
ਗএ
ʷௐ෦सfҢਪ˼d೯࢝ɨ̘d
؈ܝ
̙ঐ
ܣ
ᅵk˼Ⴍd̙ɽ̙ʃdɽՑ̙˸ɨ
ٮ
ᆖ
ᙻe፷ၺϗఙfॆԴҢዄːʘf
ה
˸dซሗઆ
ࡁ
j
ޟ
ჿ݊ɨ
ٮ
ਗএʷௐ෦सk
षΪ
މ
ОkϞ
ޟ
ჿसًk
ࠅ
ආɓӉЪԬ
ޟ
ჿᏨ
ݟ
kϞ
ޟ
ჿ፬
ج
̙˸ཫԣkᑽᑽf
ᛘ٫
ગ˻ࢎ
2009
ϋ
8
˜
㕱㖃㕿Ϟɓ
೯ࡈ
࢝ٙཀ
ASO
Ϟɓ
೯ࡈ
࢝ٙཀfཀٙᘌࠠ
ܓ
ၾॹАٙ
ܓ
ѕΥfϘಂdઃ٫੬Ϟɨ
૭೯ٮ
e
௦˝ٙชᙂdගϞၺЄЂٙ
פ
ഊdϤಂׁൖd
א
Ⴌ˸
މ
݊ॹඑe৶ሯଯᕦഃϼɛष
ה
ߧ
fΪϤdˈՉ݊ϼϋɛd̀̋˸ᙆઑd੬Ϟ໔೨e௦ຌࣛd
ࠅ
ซՑவ
ࡈ
षdϘఱൢeϘ
ط
ᐕfνॹАʔՑҷഛdఱึ̈ତග๊ർБٙसًfу¨ББ৾৾d৾৾ББ©ًٙ࿒f
வ݊͟
ݺ
ਗ̋ࠠॹःϾ़͛೨d๊ࢹԴॹःᇠ༆ϾԴ़೨ಯჀfᎇഹॹАٙ̋ࠠdఱึ̈ତʔ
ਗ͵೨ٙ᎑ࢹ೨fϤʊͪd̀ጐ
ط
ᐕdщ
ۆ
ආɓӉ೯࢝dఱึආɝᕸϥಂdϾࠦᑗ࿚
ٮ
ʘ೨d
אޟ
Κʿ͛նəf
ཫԣ㕱㖃㕿ٙ
ࠅ
ჯ
ɓeΪ
މ
ASO
ֻֻ݊͟৷АᏀeጟ҇षഃशष
ה
ˏৎٙdΪϤd
ࠅ
ཫԣவԬशषٙ೯͛fɓ͇೯ତઃɪவ
Ԭशषࣛdఱ
ࠅ
ᘌࣸ፭ςᔼ͛ٙᜟծdࠥ͜АᏀeࠥАጟٙᖹ
ي
dЪጐٙ
ط
ᐕf
ɚeභ
ءࠅ
จᒒе
א
ˇ৷ጟe৷ইe৷ᑔոቐe৷ഃঐˏ
ߧ
ਗএʷٙ
ي
iආෳϷ̋
3
ই
ٴ
აeၪ͛९
C
ഃঐཫԣਗএഎᅵʷٙ
ي
f
ɧe
ࠅ
ਂቇඎٙ༶ਗd੬ᒦd̙˸ᄣ੶А၍ٙᅁdԣ˟А၍ᓴʷd
ڮ
ආА૰ృᐑf
̬e
ڭ
ܵːଣ̻ፅdᒒе
ڗ
ࣛಂٙઋၫၡੵձᏀҵf
ྡ㕞㕐ඎԑሶАᏀ
໔ɰ
ࠅ
ඎАᏀ
͟ɪ
ࠑ
̙ԈdϘಂᆽൢ
ASO
ྼ᙮ࠠ
ࠅ
d
ה
˸षɛᏐՑϞА၍̮߅ਖ਼߅ٙᔼ৫ఱ
ᔼd˸Ӌᆽൢfତί߅ኪٙᏨ
ݟ
˓
ܘݬ
εdνೌ௴ෆٙɨ
ٮ
А
ݴ
ʱؓᄃeɨ
ٮ
ਗএ
Ѝ൴ᑊe
CT
eࣨှࣈഃfШͦ
ۃ
dක௰੬ٙ͜ൢᓙ˙
ج
݊jஷཀඎԑሶٙϗᐵ
АᏀ
(
Ԉྡ
)
ձɪᑑٙϗᐵАᏀd͜
٫ۃ
ၾ
٫ܝ
ٙˢ
࠽
dӋ̈ሶᑑܸᅰdЪ̈кᓙf
ɓছႩ
މ
jܸᅰ
> 0.90
މ
͍੬i
0.41-0.90
މ
Ⴠฆ
א
ʕ
ܓ
ASO
i
0.00-0.40
މ
ᘌࠠ
ASO
f
໔ɰ
ࠅ
ඎАᏀk
ɨ
ٮ
ਗএʷௐ෦स
ɨ
ٮ
ਗএʷௐ෦स
(lower extremity arteriosclerosis obliterans,
ASO)
݊ɓ၇А၍शषd̙ኬ
ߧ
ɨ
ٮ
А၍ഢᐵ॥ձ၍ᓴᜊfА
ݴ
ඎࠥЭdԴଡ଼ᔌձग़աՑฦf
ࡡΪ݊͟ਗএА၍ᓴɪҖϓ෯dΣА၍ഢlz߉ৎdԨʔᓙ
ᄣ͛ᓒɽdᎇഹАʃؐίՉɪၳጐdϾҖϓАࣼfА၍ഢᜊ൳Ը
൳॥d
ޟ
ЇҁΌௐ෦dഐ
؈
݊А૰
ݴ
ਗٙ
ܓ
ᜊ࿔eА
ݴ
ඎಯˇd
̈ତ
ܢ
࿔א
ٙଡ଼ᔌॹАfᘌࠠࣛኬ
ߧ
ଡ଼ᔌٙᕸϥf